NLRP3 and diabetic kidney disease: Similarly, Ginsenoside Rg5 has been shown to diminish inflammatory responses by inhibiting the activation of the NLRP3 inflammasome, consequently reducing blood glucose, creatinine, and urea nitrogen levels in mice with diabetic nephropathy (DN) (55).